Differences in Non-Hodgkin lymphoma survival between young adults and children

Archives of Pediatrics and Adolescent Medicine

Volumn 164, Issue 3, 2010, Pages 218-224

  Tai, Eric ^a   Pollack, Lori A ^a   Townsend, Julie ^a   Li, Jun ^a   Steele, C Brooke ^a   Richardson, Lisa C ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HISTOLOGY; HUMAN; HUMAN TISSUE; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; AGE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; MORTALITY; MULTIVARIATE ANALYSIS; NEWBORN; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOMA, NON-HODGKIN; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 77950367289     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2010.4     Document Type: Article

References (28)

1. Zebrack B, Bleyer A, Albritton K, Medearis S, Tang J. Assessing the health care needs of adolescent and young adult cancer patients and survivors. Cancer. 2006; 107(12):2915-2923.
2. Horner MJ, Ries LA, Krapcho M, et al. SEER cancer statistics review, 1975-2006. http://seer.cancer.gov/csr/1975-2006/index.html. Accessed November 11, 2009.
3. Hampton T. Cancer treatment's trade-off: years of added life can have long-term costs. JAMA. 2005;294(2):167-168.
4. Bleyer A, O'Leary M, Barr R, Ries LA, eds. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000. Bethesda, MD: National Cancer Institute; 2006. NIH publication 06-5767.
5. National Vital Statistics System, National Center for Health Statistics, Centers for Disease Control and Prevention. Ten leading causes of death by age group, United States - 2006. http://www.cdc.gov/injury/Images/LC-Charts/10lc%20- %20By %20Age%20Group%202006-7-6-09-a.pdf. Accessed December 31, 2009.
6. Bleyer A, Viny A, Barr R. Cancer in 15- to 29-year-olds by primary site. Oncologist. 2006;11(6):590-601.
7. Bleyer A, Montello M, Budd T, Saxman S. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer. 2005;103(9):1891-1897.
8. Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006;107(7)(suppl):1645-1655.
9. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) Program: SEER*Stat database: incidence - SEER 17 regs limited-use + Hurricane Katrina Louisiana impacted cases, Nov 2007 submission (1973-2005 varying) - linked to county attributes - total US, 1969-2005 counties. Bethesda, MD: National Cancer Institute; 2008.
10. National Cancer Institute. Number of Persons by Race and Hispanic Ethnicity for SEER Participants (2000 Census Data). Bethesda, MD: National Cancer Institute; 2000.
11. Cancer Statistics Branch Surveillance Program, National Cancer Institute. SEER Extent of Disease, 1988: Codes and Coding Instructions. Bethesda, MD: Cancer Statistics Branch Surveillance Program, National Cancer Institute; 1998.
12. Venugopal P, Gregory SA. Lymphoproliferative disorders. In: Kahn MJ, Gregory SA, eds. American Society of Hematology Self-Assessment Program. Washington, DC: American Society of Hematology; 2007.
13. Vose JM, Link BK, Grossbard ML, et al. Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2001;19(2):389-397.
14. Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol. 2005;23(22):5027-5033.
15. Morton LM, Wang SS, Cozen W, et al. Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood. 2008;112(13):5150-5160.
16. Gérard L, Galicier L, Maillard A, et al.Systemicnon- Hodgkinlymphomain HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr. 2002;30(5):478-484.
17. Burke ME, Albritton K, Marina N. Challenges in the recruitment of adolescents and young adults to cancer clinical trials. Cancer. 2007;110(11):2385-2393.
18. Bleyer WA, Tejeda H, Murray SB, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health. 1997;21(6):366-373.
19. Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290(21):2831-2837.
20. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van't Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol. 2003;21(18):3431-3439.
21. Kriss JL, Collins SR, Mahato B, Gould E, Schoen C; Commonwealth Fund. Rite of passage? why young adults become uninsured and how new policies can help, 2008 update. http://www.commonwealthfund.org/Content/Publications /Fund-Reports/2008/May/Rite-of-Passage--Why-Young-Adults-Become -Uninsured-and-How-New-Policies-Can-Help--2008-Update.aspx. Accessed November 11, 2009.
22. Glied S, Mahato B; Commonwealth Fund. Analysis of the March 2007 current population survey. http://www.commonwealthfund.org/~/media/Files/Publications /Fund%20Report/2008/May/Rite%20of%20Passage%20%20Why%20Young %20Adults%20Become%20Uninsured%20and%20How%20New%20Policies %20Can%20Help%20%202008%20Update/Kriss-riteofpassage2008-figures %20pdf.pdf. Accessed November 11, 2009.
23. Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A. Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist. 2007; 12(7):816-824.
24. Bleyer A. Young adult oncology: the patients and their survival challenges. CA Cancer J Clin. 2007;57(4):242-255.
25. Adolescent and Young Adult Oncology Progress Review Group. Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults With Cancer: Report of the Adolescent and Young Adult Oncology Progress Review Group. Bethesda, MD: National Institutes of Health, National Cancer Institute, LiveStrong Young Adult Alliance; 2006. NIH publication 06-6067.
26. Hewitt M, Greenfield S, Stovall E, eds; Institute of Medicine; National Research Council. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academies Press; 2005. http://www.iom.edu/Reports/2005 /From-Cancer-Patient-to-Cancer-Survivor-Lost-in-Transition.aspx. Accessed November 11, 2009.
27. Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers, version 3.0. http://www .childrensoncologygroup.org/disc/LE/. Accessed November 11, 2009.
28. Wingo PA, Jamison PM, Hiatt RA, et al. Building the infrastructure for nationwide cancer surveillance and control: a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control. 2003;14(2): 175-193.